U.S. Government Purchases $1 Billion More of Merck COVID-19 Pill, Molnupiravir
Merck and Ridgeback Biotherapeutics announced the U.S. government committed to purchase an additional 1.4 million courses of molnupiravir, an investigational oral antiviral medicine. The $1...










